会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明专利
    • Autonomic nerve regulator
    • 自动神经调节器
    • JP2011126833A
    • 2011-06-30
    • JP2009288305
    • 2009-12-18
    • Gekkeikan Sake Co LtdOsaka Bioscience Institute月桂冠株式会社財団法人大阪バイオサイエンス研究所
    • TSUTSUMI HIROKOSUZUKI SACHIKOHATA YOJIABE YASUHISAURADE YOSHIHIROHUANG ZHI-LIMATSUMOTO NAOMIMASAKI MIKA
    • A61K36/00A23L1/30A23L2/38A23L2/52A61K36/899A61P25/02
    • PROBLEM TO BE SOLVED: To provide an autonomic nerve regulator utilizing an intermediate, a final product and their processed materials yielded at the production processes of sake, such as a sake lees-processed material.
      SOLUTION: This autonomic nerve regulator includes the sake lees-processed material yielded by the liquefied preparation of sake. The sake lees-processed material is obtained by performing at least one treatment selected from the group consisting of the following (1) to (3) on the sake lees. In (1) protease treatment, (2) cellulase treatment, and (3) lactobacillus fermentation treatment, and it is preferable to use a neutral protease or an acidic protease in the protease treatment, to use endoglucanase or cellobiohydrolase in the cellulase treatment, and to use Lactobacillus brevis, Lactobacillus bulgaricus, etc., in the lactobacillus fermentation treatment.
      COPYRIGHT: (C)2011,JPO&INPIT
    • 要解决的问题:提供利用中间体,最终产品及其在清酒生产过程中产生的最终产品及其加工材料的自主神经调节剂,例如酒精加工材料。

      解决方案:这种自主神经调节剂包括由液化液制成的清酒产品。 通过在清酒桶中进行选自由以下(1)至(3)组成的组中的至少一种处理,从而获得食品加工材料。 在(1)蛋白酶处理,(2)纤维素酶处理和(3)乳酸杆菌发酵处理中,优选在蛋白酶处理中使用中性蛋白酶或酸性蛋白酶,在纤维素酶处理中使用内切葡聚糖酶或纤维二糖水解酶, 在乳杆菌发酵处理中使用短乳杆菌(Lactobacillus brevis),保加利亚乳杆菌(Lactobacillus bulgaricus)等。 版权所有(C)2011,JPO&INPIT

    • 3. 发明专利
    • Iron supplement and utilization of the same
    • 铁的补充和利用
    • JP2005225874A
    • 2005-08-25
    • JP2005006829
    • 2005-01-13
    • Gekkeikan Sake Co Ltd月桂冠株式会社
    • SUZUKI SACHIKOFUKUDA KATSUHARUIRIE MOTOKOHATA YOJIKAWATO SHOJIABE YASUHISA
    • A23L2/52A23L1/304A61K31/395A61K33/26A61K36/06A61P7/06
    • PROBLEM TO BE SOLVED: To obtain an iron supplement exhibiting a high iron absorption rate into a living body, a preventing or treating agent of iron-deficiency anemia, a food additive and a food composition. SOLUTION: This iron supplement, the preventing or treating agent of the iron deficiency anemia, the food additive or the food composition contains siderophore and ferric ion preferably as a chelate complex form. The chelate complex of the siderophore with ferric ion has a high absorption rate into the living body, increases hemoglobin concentration in blood, iron concentration in serum and stored iron concentration in liver by being absorbed in the living body and does not give any adverse effect on living body functions. COPYRIGHT: (C)2005,JPO&NCIPI
    • 要解决的问题:获得在生物体中表现出高的铁吸收率的铁补充剂,缺铁性贫血的预防或治疗剂,食品添加剂和食物组合物。 解决方案:该铁补充剂,缺铁性贫血的预防或治疗剂,食品添加剂或食物组合物优选含有铁螯合物和铁离子作为螯合络合物形式。 铁载体与铁离子的螯合物对人体的吸收率高,血液中血红蛋白浓度升高,血液中铁浓度升高,肝脏中铁浓度被吸收在生物体内,不会对生物体产生不利影响 活体功能。 版权所有(C)2005,JPO&NCIPI
    • 4. 发明专利
    • Hypotensive composition using koji
    • 使用KOJI的HYPOTENSIVE组合物
    • JP2008247888A
    • 2008-10-16
    • JP2008039965
    • 2008-02-21
    • Gekkeikan Sake Co Ltd月桂冠株式会社
    • SUZUKI SACHIKOISHIDA HIROKI
    • C07K5/103A61K36/06A61K38/00A61P9/12A61P43/00C12N9/99C12P21/06
    • Y02P20/52
    • PROBLEM TO BE SOLVED: To provide an angiotensin converting enzyme inhibitor which is available at a low cost and does not cost much labor since the use of the angiotensin converting enzyme inhibitor as a medical treatment drug has to be based on the prescription of a doctor and furthermore, its cost is high and, in the case of using an angiotensin converting enzyme inhibiting peptide, a treatment such as hydrolysis of each peptide is required and extraction and the like cost much labor. SOLUTION: It is found that the angiotensin converting enzyme inhibition activity exists in koji and the extract of koji with water and it is found that the angiotensin converting enzyme inhibition activity showing digestive enzyme resistance also exists in a peptide obtained by partially decomposing proteins present in koji and the peptide has been identified. Further, the blood-pressure reduction by intake of koji has been confirmed in the human monitoring test. COPYRIGHT: (C)2009,JPO&INPIT
    • 要解决的问题:提供一种以低成本获得并且不会花费太多劳动的血管紧张素转化酶抑制剂,因为使用血管紧张素转换酶抑制剂作为医疗治疗药物必须基于 医生,此外,其成本高,并且在使用血管紧张素转化酶抑制肽的情况下,需要诸如各种水解的处理,并且提取等费用昂贵。 解决方案:发现血管紧张素转换酶抑制活性存在于曲和曲水提取物中,发现显示消化酶抗性的血管紧张素转换酶抑制活性也存在于通过部分分解蛋白获得的肽 存在于曲和肽已被鉴定。 此外,在人体监测试验中已经确认了通过摄入曲调的血压降低。 版权所有(C)2009,JPO&INPIT
    • 7. 发明专利
    • Preventing or improving agent of fatigue
    • 防止或改善疲劳剂
    • JP2007091711A
    • 2007-04-12
    • JP2006180060
    • 2006-06-29
    • Gekkeikan Sake Co Ltd月桂冠株式会社
    • SUZUKI SACHIKOFUKUDA KATSUHARUIRIE MOTOKOHATA YOJIKAWATO SHOJIABE YASUHISAYASUI HIROYUKISAKURAI HIROSHI
    • A61K35/66A23L1/304A23L1/305A61K33/26A61K38/00A61K38/16A61P3/02
    • PROBLEM TO BE SOLVED: To provide a preventing or improving agent of muscular fatigue, capable of improving the durability of the muscle, the preventing or improving agent of fatigue caused by the lack of iron and a food composition. SOLUTION: In the case that siderophore or a chelate complex of the siderophore with ferric ion is orally administered, it is found out each of the facts that the iron is absorbed in a good efficiency in a living body and distributes much in the muscle, and that the distribution rate in the muscle is very high as compared with that of inorganic iron. Also, by the oral administration of the siderophore or the chelate complex of the siderophore with ferric ion, it is found out that as compared with the administration of the inorganic iron, the durability of the muscle becomes higher, the stored amount of iron in the living body is increased as the content of iron in the muscle tissue increases, prevention and improvement of anemia, improvement of stamina and alleviation effects of tiredness or weariness are obtained. COPYRIGHT: (C)2007,JPO&INPIT
    • 解决问题:提供肌肉疲劳的预防或改善剂,能够提高肌肉的耐久性,防止或改善缺乏铁和食物组合物引起的疲劳。

      解决方案:在铁载体与铁离子的螯合络合物口服给药的情况下,发现铁在生物体中以良好的效率吸收的各种事实,并且分布在 肌肉,与无机铁相比,肌肉中的分布率非常高。 此外,通过口服铁载体的铁载体或螯合络合物与铁离子的配合,发现与无机铁的施用相比,肌肉的耐久性变高,铁的存储量 随着肌肉组织中铁含量的增加,活体的增加,贫血的预防和改善,耐力的提高和疲劳或疲劳的缓解作用得到改善。 版权所有(C)2007,JPO&INPIT

    • 9. 发明专利
    • Oral ingestion material
    • 口腔材料
    • JP2008050269A
    • 2008-03-06
    • JP2006224999
    • 2006-08-22
    • Gekkeikan Sake Co Ltd月桂冠株式会社
    • SUZUKI SACHIKOOURA ARATAFUKUDA KATSUHARUIRIE MOTOKO
    • A61K31/197A23L1/30A61K35/74A61K36/899A61K38/55A61P9/12A61P43/00
    • PROBLEM TO BE SOLVED: To obtain a composition of natural raw material effective for treatment of hypertension and having no adverse effect in which γ-aminobutyric acid being a kind of an amino acid existing in the natural world is a material having a noticeable effect as antihypertensive agent and even a low γ-aminobutyric acid content, more enhances high hypotensive effect of γ-aminobutyric acid. SOLUTION: The composition containing γ-aminobutyric acid is obtained by reacting by-product of refined rice wine brewing as a raw material with lactic acid bacterium. The raw material may comprise rice bran and/or glutamic acid or its salt. The composition exhibits a strong hypotensive effect more than a case of ingesting only γ-aminobutyric acid alone. When both the composition and an ACE (angiotensin converting enzyme) inhibitory peptide are used, even the amount of each component is small, it is found that a synergistic effect is obtained and a strong hypotensive effect is exhibited. COPYRIGHT: (C)2008,JPO&INPIT
    • 要解决的问题:为了获得有效治疗高血压的天然原料的组合物,并且不存在γ-氨基丁酸作为存在于天然世界中的一种氨基酸的不利影响的物质是具有明显的物质 作为抗高血压药物甚至低γ-氨基丁酸的含量,更能增强γ-氨基丁酸的高血压降低作用。 解决方案:含有γ-氨基丁酸的组合物通过将精制米酒酿造作为原料的副产物与乳酸菌反应而获得。 原料可以包含米糠和/或谷氨酸或其盐。 与单独摄入γ-氨基丁酸的情况相比,该组合物具有强烈的降血压作用。 当使用组合物和ACE(血管紧张素转换酶)抑制肽两者时,即使每种组分的量都很小,发现获得了协同效应并且表现出强烈的降血压作用。 版权所有(C)2008,JPO&INPIT